drugset / Trial / NCT04909905

Glutamine Supplementation and Short-term Mortality in Covid-19

NCT04909905

Phase 3 Completed 60 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to investigate the effect of parenteral L-Glutamine supplementation added to enteral nutrition on short-term ICU mortality (7 days) in Covid-19 diseased patients.

Timeline

Start
2021-05-30
Primary completion
2021-10-25
Completion
2021-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutamine Other / unclassified 0.4 g/kg Intravenous

Indications